TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹55 Cr | ₹21 Cr | ₹12 Cr | ₹7.62 Cr |
What is the latest Total Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹7.62 Cr |
How is Total Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 163.62 | |
| Mar2024 | ₹21 Cr | 76.55 | |
| Mar2023 | ₹12 Cr | 55.64 | |
| Mar2022 | ₹7.62 Cr | - | |
Compare Total Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹348.0 Cr | 3.4% | 2.8% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 3.4% |
2.8% |
11.5% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses